Douglas Levine
MD
Chief, Gynecology Service
👥Biography 个人简介
Douglas Levine at MSK co-led the TCGA (The Cancer Genome Atlas) molecular characterization of endometrial cancer — establishing four molecular subtypes: POLE ultramutated (excellent prognosis), microsatellite instability high/hypermutated, copy number low, and copy number high/serous-like (poor prognosis). This molecular classification has been incorporated into the revised 2023 FIGO staging for endometrial cancer and is transforming treatment stratification.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Douglas Levine 的研究动态
Follow Douglas Levine's research updates
留下邮箱，当我们发布与 Douglas Levine（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment